For The Better

This dominant retail chain has been a fantastic performer for shareholders.

The stock hasn’t made for a great buy this year, but is Vertex worth investing in for the long run?

Is it too late to buy these impressive growth stocks?

A price target of $235 might seem ambitious in light of the stock’s recent run, but it could prove to be conservative.

On this episode of FYI, ARK Multiomics analyst Nemo Marjanovic sits down with Professor George Church, a renowned geneticist and entrepreneur from Harvard.

These two fast-growing restaurant chains have plenty of runway ahead of them to expand, but one is better positioned than the other.

NextEra Energy Partners has a huge 11%-plus yield that could be viewed as an opportunity — or a sign that the good times are over.

Investors might not be familiar with this under-the-radar discount retailer.

Google is the latest cloud giant to invest in custom CPUs for its data centers.

This company has proven its innovative abilities, but that’s not enough to outperform the market.

The enigmatic chief executive says, “The consequences will be extraordinary.”

How long can price increases sustain a declining business?

Amgen’s stock isn’t expensive, but the business does face some challenges, which could have investors thinking twice.

Is it too late to buy after it doubled last year?

Cigarette volumes are plummeting and the industry’s heyday is long gone. But one of these giants has done better at building for the future.

What dividend investor wouldn’t want to own a REIT with a 14.8% dividend yield? Investors that don’t like dividend cuts.

These stocks are rallying for excellent reasons.

SoundHound AI has attracted a lot of interest from investors this year, but a superior technology may have just emerged.

Investor Bill Ackman is legendary for his big bets. Howard Hughes Holdings is one of his biggest.

Not all stocks are expensive right now. These two dividend stocks look like excellent long-term opportunities.